title: Integrating safety and efficacy evaluation throughout vaccine research and development.
authors.affiliation: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, 6610 Rockledge Dr, MSC 6604, Bethesda, MD 20892-6604, USA.
authors.forename: George
authors.initials: G
authors.lastname: Curlin
authors.forename: Sarah
authors.initials: S
authors.lastname: Landry
authors.forename: Jessica
authors.initials: J
authors.lastname: Bernstein
authors.forename: Richard L
authors.initials: RL
authors.lastname: Gorman
authors.forename: Barbara
authors.initials: B
authors.lastname: Mulach
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Hackett
authors.forename: Stephanie
authors.initials: S
authors.lastname: Foster
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Miers
authors.forename: Patricia
authors.initials: P
authors.lastname: Strickler-Dinglasan
mesh_terms: D003140:Communicable Disease Control / Q000379:methods; D004341:Drug Evaluation; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D017589:Immunization Programs; D012106:Research; D017751:Safety Management; D014481:United States; D014611:Vaccination / Q000009:adverse effects / Q000379:methods; D014612:Vaccines / Q000276:immunology* / Q000494:pharmacology*
chemical_list: D014612:Vaccines